Related Experiment Video
Updated: Jun 4, 2026
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Airway molecular phenotypes in pediatric asthma
Shean J Aujla1, Kristie R Ross, James F Chmiel
1Division of Pulmonary Medicine, Allergy and Immunology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, USA. shean.aujla@chp.edu
Current Opinion in Allergy and Clinical Immunology
|March 2, 2011
Summary
Identifying noninvasive biomarkers for pediatric asthma phenotypes is crucial. While some markers show promise, further research is needed for routine clinical use in managing childhood asthma.
Area of Science:
- Pediatric Pulmonology
- Biomarker Discovery
- Asthma Pathogenesis
Background:
- Pediatric asthma is a complex, heterogeneous condition with diverse clinical presentations.
- Understanding the molecular underpinnings of asthma phenotypes is key to developing targeted therapies.
- Numerous inflammatory markers have been investigated to elucidate asthma's pathogenesis.
Purpose of the Study:
- To review current knowledge on airway molecular phenotypes in pediatric asthma.
- To examine biomarkers studied in relation to distinct clinical asthma phenotypes in children.
- To assess the potential of these biomarkers in understanding and managing pediatric asthma.
Main Methods:
- Literature review of studies on airway molecular phenotypes and biomarkers in pediatric asthma.
- Analysis of less invasive inflammatory markers compared to bronchoalveolar lavage.
- Evaluation of biomarkers including exhaled nitric oxide, exhaled breath condensate, urine leukotriene E4, and induced sputum.
Main Results:
- Several less invasive biomarkers (exhaled nitric oxide, exhaled breath condensate, urine leukotriene E4, induced sputum) reflect airway inflammation in children.
- These biomarkers offer potential for classifying and managing pediatric asthma.
- Current data suggest utility, but further validation is required for routine clinical application.
Conclusions:
- Continued research into noninvasive biomarkers for pediatric asthma is essential.
- Elucidating specific molecular phenotypes will improve diagnosis and treatment strategies.
- Prioritizing biomarker discovery will advance the care and management of children with asthma.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...